The DOI matches its Crossref record; 135 of the 138 references it cites were found in a registry or an index.
HRT for women with premature ovarian insufficiency: a comprehensive review
Open accessAbstract
BACKGROUND: Premature ovarian insufficiency (POI), often and misleadingly referred to as 'premature menopause', is defined as a loss of ovarian activity before the age of 40 years and is characterized by irregular or absent periods and reduced fertility. Symptoms include those associated with the natural menopause (night sweats and vaginal dryness), and with the long-term adverse effects of estrogen deficiency (osteoporosis and cardiovascular disease): the latter is believed to explain the shorter life expectancy associated with POI. OBJECTIVE AND RATIONALE: The objective of the current review was to collect all relevant studies supporting recommendations on the indications, treatment options, and risks of hormone replacement therapy (HRT) (estrogen, progestogens and androgens) for women with POI. SEARCH METHODS: The current review was written based on the best available evidence on the topic collected for the recently published ESHRE guideline on the management of women with POI. PUBMED/MEDLINE and the Cochrane library were searched in a stepwise approach. Relevant references were summarized in evidence tables, with assessment of the quality. OUTCOMES: HRT is strongly recommended for women with POI, mainly for vasomotor and genito-urinary symptom relief. In addition, HRT has been shown to have a role in bone protection and probably also in primary prevention of cardiovascular disease. There is little evidence on the optimal type, regimen and dose of HRT; patient preference for route and method of administration of each component of HRT must be considered when prescribing, as should contraceptive needs. In women with POI, physiological replacement of estrogen (and progesterone) is essential for their health, and the controversies that surround the use of HRT in postmenopausal women do not apply. LIMITATIONS REASONS FOR CAUTION: N/A. WIDER IMPLICATIONS: New areas of study on HRT for women with POI should focus on life expectancy, quality of life and neurological function. Furthermore, randomized controlled trials comparing transdermal estradiol with oral estrogens with regard to efficacy, patient satisfaction and side effects are urgently needed. STUDY FUNDING/COMPETING INTERESTS: The authors received no funding for the review. The costs for the development of the ESHRE guideline were covered by ESHRE. The authors have no conflicts of interest to disclose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they are a non-standardized mixture of many different estrogens and metabolites”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [283]
In the citing paper
“Conjugated equine estrogens are no longer recommended because they increase the risk of venous thromboembolism”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [283]
In the citing paper
“Vaginal E2 is not believed to carry a risk of endometrial hyperplasia based on data in older menopausal women.283”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [283]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Breast cancer and hormone-replacement therapy in the Million Women Study
Beral, V. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,986
Calle, E. E., Heath Jr., C. W., Coates, R. J., Liff, J. M., Franceschi, S., Talamini, R., Chantarakul, N., Koetsawang, S., Rachawat, D., Morabia, A., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08233-0 · Cited by 2,450
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
ESHRE Guideline: management of women with premature ovarian insufficiency
The ESHRE Guideline Group on POI, Webber, L. J., Davies, M. C., Anderson, R. A., Bartlett, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,603
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., REEVES, G. K., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,270
Nelson, L. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0808697 · Cited by 1,189
Incidence of Premature Ovarian Failure
Coulam, C. B., Adamson, S. C., & Annegers, J. F. (1987) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198703000-00020 · Cited by 1,024
Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group
Bondy, C. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1374 · Cited by 1,005
Cited by
Sorted by citations
Premature ovarian insufficiency: an international menopause society white paper
Panay, N., Anderson, R. A., Nappi, R. E., Vincent, A. J., Vujovic, S., Webber, L., & Wolfman, W. (2020) · Climacteric · doi:10.1080/13697137.2020.1804547 · Cited by 297
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Fiorentino, G., Cimadomo, D., Innocenti, F., Soscia, D. M., Vaiarelli, A., Ubaldi, F. M., Gennarelli, G., Garagna, S., Rienzi, L. F., & Zuccotti, M. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac031 · Cited by 190
Cho, J., Kim, T., Seok, J., Jun, J. H., Park, H., Kweon, M., Lim, J., & Kim, G. J. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00513-1 · Cited by 89
Deng, T., He, J., Yao, Q. Y., Wu, L., Xue, L., Wu, M., Wu, D., Li, C., & Li, Y. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00499-1 · Cited by 86
The influence of the gut microbiome on ovarian aging
Huang, F., Cao, Y., Liang, J., Tang, R., Wu, S., Zhang, P., & Chen, R. (2024) · Gut Microbes · doi:10.1080/19490976.2023.2295394 · Cited by 93
Primary ovarian insufficiency: update on clinical and genetic findings
Federici, S., Rossetti, R., Moleri, S., Munari, E. V., Frixou, M., Bonomi, M., & Persani, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1464803 · Cited by 96
Menopausal hormone therapy and breast cancer risk
Rozenberg, S., Pietrantonio, V. D., Vandromme, J., & Gilles, C. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101577 · Cited by 79
Sex hormone replacement therapy in Turner syndrome—impact on morbidity and mortality
Viuff, M. H., Berglund, A., Juul, S., Andersen, N. H., Stochholm, K., & Gravholt, C. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz039 · Cited by 62
Pu, X., Zhang, L., Zhang, P., Xu, Y., Wang, J., Zhao, X., Dai, Z., Zhou, H., Zhao, S., & Fan, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1205901 · Cited by 59
BCAA insufficiency leads to premature ovarian insufficiency via ceramide‐induced elevation of ROS
Guo, X., Zhu, Y., Guo, L., Qi, Y., Liu, X., Wang, J., Zhang, J., Cui, L., Shi, Y., Wang, Q., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317450 · Cited by 56
Diagnosis and management of premature ovarian insufficiency
Rahman, R., & Panay, N. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101600 · Cited by 58
Manchanda, R., Gaba, F., Talaulikar, V. S., Pundir, J., Gessler, S., Davies, M. C., & Menon, U. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16896 · Cited by 53
Shin, E., Kim, D., Lee, M. J., Lee, A. R., Shim, S. H., Baek, S. W., Han, D. K., & Lee, D. R. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02479-3 · Cited by 56
The Treatment of Complementary and Alternative Medicine on Premature Ovarian Failure
Lin, J., Wu, D., Jia, L., Liang, M., Liu, S., Qin, Z., Zhang, J., Han, Y., Liu, S., & Zhang, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6677767 · Cited by 46
Price, M., Alvarado, B., Rosendaal, N. T. A., da Câmara, S. M. A., Pirkle, C. M., & Vélez, M. P. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001729 · Cited by 46
Premature ovarian insufficiency
Kapoor, E. (2023) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2023.100435 · Cited by 42
Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism
Jayasena, C. N., Devine, K., Barber, K., Comninos, A. N., Conway, G. S., Crown, A. L., Davies, M. C., Ewart, A., Seal, L., Smyth, A., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.15097 · Cited by 45
Guo, C., Ma, Y., Situ, Y., Liu, L., Luo, G., Li, H., Ma, W., Sun, L., Wang, W., Weng, Q., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1165574 · Cited by 36
Khallaf, W. A. I., Sharata, E. E., Attya, M. E., Rofaeil, R. R., Khalaf, M. M., Hemeida, R. A. M., & Abo‐Youssef, A. M. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117373 · Cited by 36
Varianten der Geschlechtsentwicklung in der Frauenheilkunde
Malliou-Becher, M.-N., Vogt, P. H., Capp, E., & Frank‐Herrmann, P. (2020) · Gynäkologische Endokrinologie · doi:10.1007/s10304-020-00358-3 · Cited by 34
Costa, G. P. O., Filho, E. S. F., Simões, R. S., Soares, J. M., Baracat, E. C., & Maciel, G. A. R. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.09.011 · Cited by 34
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
Stevenson, J. C., Rozenberg, S., Maffei, S., Egarter, C., Stute, P., & Römer, T. (2020) · Drugs in Context · doi:10.7573/dic.2020-10-1 · Cited by 33
Hickey, M., Moss, K. M., Krejany, E. O., Wrede, C. D., Brand, A. H., Kirk, J., Symecko, H., Domchek, S. M., Tejada‐Berges, T., Trainer, A. H., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.07.029 · Cited by 30
Fragile X premutation and associated health conditions: A review
Tassanakijpanich, N., Hagerman, R. J., & Worachotekamjorn, J. (2021) · Clinical Genetics · doi:10.1111/cge.13924 · Cited by 30
AlSwayied, G., Guo, H., Rookes, T., Frost, R., & Hamilton, F. L. (2022) · JMIR mhealth and uhealth · doi:10.2196/40271 · Cited by 40
Pellikaan, K., Brahim, Y. B., Rosenberg, A. G. W., Davidse, K., Poitou, C., Coupaye, M., Goldstone, A. P., Höybye, C., Markovic, T., Grugni, G., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245781 · Cited by 30
Yamchi, N. N., Rahbarghazi, R., Bedate, A. M., Mahdipour, M., Nouri, M., & Khanbabaee, R. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3669 · Cited by 28
Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis
Gonçalves, C. R., de Vasconcellos, A. S., Rodrigues, T. R., Comin, F. V., & dos Reis, F. M. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.02.006 · Cited by 27
Chen, S. X., Lu, Y., Chen, Y., Xu, J., Chen, L., Zhao, W., Wang, T., Wang, H., & Wang, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113996 · Cited by 27
Fu, L., Wang, M., Li, D., Ma, S., Zhang, F.-L., & Zheng, L. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1624415 · Cited by 25
Rare deleterious BUB1B variants induce premature ovarian insufficiency and early menopause
Chen, Q., Ke, H., Luo, X., Wang, L., Wu, Y., Tang, S., Li, J., Li, J., Zhang, F., Qin, Y., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa153 · Cited by 25
The functional role of lncRNAs as ceRNAs in both ovarian processes and associated diseases
Usman, M., Ai, L., Wu, D., Qinyan, Y., Yi, L. X., He, G., & Lü, H. (2023) · Non-coding RNA Research · doi:10.1016/j.ncrna.2023.11.008 · Cited by 25
Molecular mechanisms underlying cyclophosphamide-induced ovarian injury and protective strategies
Sharata, E. E., Bakry, T., Atta, H. G., Mohammed, H. A., Diab, N. S., Atef, R. A., Hosney, R. S., Omar, M. M., & Hemeida, R. A. M. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04550-9 · Cited by 31
Kuang, X., Tang, Y., Xu, H. Y., Ji, M. J., & Lai, D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.855992 · Cited by 20
Endometriosis and menopause—management strategies based on clinical scenarios
Jakson, I., Hirschberg, A. L., & Gidlöf, S. B. (2023) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14583 · Cited by 19
Pan, R., Wang, R., Cheng, F., Wang, L., Cui, Z., She, J., & Yang, X. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01208-8 · Cited by 20
Menopausal hormone therapy for women living with HIV
King, E. M., Prior, J. C., Pick, N., van Schalkwyk, J., Kestler, M., Tkachuk, S., Loutfy, M. R., & Murray, M. C. M. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(21)00148-x · Cited by 18
A meta-analysis of serum lipid profiles in premature ovarian insufficiency
Wang, Z., Fang, L., Wu, Z., Li, Y., Jia, Q., Cheng, J., & Sun, Y. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.09.018 · Cited by 21
A comprehensive review of the new FIGO classification of ovulatory disorders
Balen, A. H., Tamblyn, J. A., Skorupskaite, K., & Munro, M. G. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmae003 · Cited by 25
Stem cell transplantation extends the reproductive life span of naturally aging cynomolgus monkeys
Long, Y., Tu, W., Zhao, X., Wan, H., Wu, J., Zhao, Y. G., Wu, J., Sun, Y., Zhu, L., Qin, Y., et al. (2024) · Cell Discovery · doi:10.1038/s41421-024-00726-4 · Cited by 19
van Zwol‐Janssens, C., Pastoor, H., Laven, J. S. E., Louwers, Y. V., & Jiskoot, G. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.107994 · Cited by 18
Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy
Upton, C. E., DANIELS, J. P., & Davies, M. C. (2021) · Climacteric · doi:10.1080/13697137.2021.1902496 · Cited by 17
Craciunas, L., Ζδουκόπουλος, Ν., Vinayagam, S., & Mohiyiddeen, L. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008209.pub2 · Cited by 16
Premature ovarian insufficiency: A hormonal treatment approach
Benetti‐Pinto, C. L., Soares, J. M., Maciel, G. A. R., Nácul, A. P., Yela, D. A., & Silva, A. C. J. D. S. R. E. (2020) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0040-1716929 · Cited by 18
Pathophysiology and management of classic galactosemic primary ovarian insufficiency
Hagen-Lillevik, S., Rushing, J. S., Appiah, L. A., Longo, N., Andrews, A., Lai, K., & Johnson, J. (2021) · Reproduction and Fertility · doi:10.1530/raf-21-0014 · Cited by 17
The Trends and Hotspots in Premature Ovarian Insufficiency Therapy from 2000 to 2022
Tong, Y., Cheng, N., Jiang, X., Wang, K., Wang, F., Lin, X., & Wang, F. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811728 · Cited by 15
Sills, E. S. (2022) · Aging Medicine · doi:10.1002/agm2.12196 · Cited by 15
Early and late complications of hematopoietic stem cell transplantation
Mikulska, M., Gualandi, F., & Anserini, P. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90242-7.00010-9 · Cited by 13
Premature and Early Menopause in Relation to Cardiovascular Disease
Schipper, I., & Louwers, Y. V. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1722318 · Cited by 12
Kauffman, R. P., Young, C., & Castracane, V. D. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111181 · Cited by 13
Mesenchymal Stem Cell-based Therapy and Female Infertility: Limitations and Advances
Ghajari, G., heydari, A., & Ghorbani, M. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220511142930 · Cited by 13
Lipid Profile in Patients With Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis
Huang, L., Wang, H., Shi, M., Kong, W., & Jiang, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.876775 · Cited by 14
Hickey, M., Trainer, A. H., Krejany, E. O., Brand, A. H., Domchek, S. M., Soo, V. P., Braat, S., & Mishra, G. D. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.10.007 · Cited by 12
Zhang, X., Lu, Y., Wu, S., Zhao, X., Li, S., Zhang, S., & Tan, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.959905 · Cited by 11
Osuka, S., Kasahara, Y., Iyoshi, S., Sonehara, R., Miyake, N., Muraoka, A., Nakamura, T., Iwase, A., & Kajiyama, H. (2023) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12556 · Cited by 11
Bao, D., Gao, L., Xin, H., & Wang, L. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01121-5 · Cited by 10
Ovarian Insufficiency and Fertility Preservation During and After Childhood Cancer Treatment
Foster, K. L., Lee, D. J., Witchel, S. F., & Gordon, C. M. (2024) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2023.0111 · Cited by 11
Fertility preservation in hematological cancer patients
Li, D., Zhao, Y., Wang, Q., Chu, M.-W., Xie, J., & Zhang, C. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03419-2 · Cited by 10
Pepin, A. N., Chesnokova, A., Pishko, A. M., Gysler, S. M., Martin, C., Smith, E., Kassick, M. E., & Taunk, N. K. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.10.023 · Cited by 10
Song, Z., Song, K., Zhao, H., He, Y., & Hu, J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20025 · Cited by 10
Lee, D. H., Park, H., You, J. H., Seok, J., Kwon, D.-W., Kim, Y. R., & Kim, G. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216531 · Cited by 10
Kruszewska, J., Laudy-Wiaderny, H., Krzywdzińska, S., Grymowicz, M., Smolarczyk, R., & Męczekalski, B. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1998437 · Cited by 10
Luo, Y., Chen, J., Ning, J., Sun, Y., Chai, Y., Xiao, F., Huang, B., Li, G., Tian, F., Hao, J., et al. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01489-y · Cited by 9
Park, H., Seok, J., You, J. H., Lee, D. H., Lim, J., & Kim, G. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416009 · Cited by 9
Park, H., Seok, J., You, J. H., Kim, J. Y., Lim, J., & Kim, G. J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02772-9 · Cited by 8
Qiu, T. H., Zhou, J., Ji, B., Yuan, L., Weng, T., & Liu, H. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01212-3 · Cited by 8
Fresh insight into premature ovarian insufficiency
Karska, P., Matonóg, A., Sieradzka, P., Kowalczyk, K., & Madej, P. (2021) · Ginekologia Polska · doi:10.5603/gp.a2021.0111 · Cited by 8
Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper
Ranger, T. A., Burchardt, J., Clift, A. K., Mei, X. W., Coupland, C. A. C., Tan, P. S., Dixon, S., Cardwell, C. R., & Hippisley‐Cox, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046701 · Cited by 8
You, F., Cao, J., Cheng, L., Liu, X., & Zeng, L. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9399261 · Cited by 8
Tian, L., Wei, Y., Jiao, B., Hao, R. X., Zhou, B., Bian, X., Wang, P., Zhou, Y., Sun, X., & Zhang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1425844 · Cited by 7
Patasova, K., Dehara, M., Mantel, Ä., Bixo, M., Arkema, E. V., & Holmqvist, M. E. (2025) · Lara D. Veeken · doi:10.1093/rheumatology/keaf004 · Cited by 7
Manukyan, G. P., Martirosyan, A., Slavík, L., Úlehlová, J., Dihel, M., Papajík, T., & Kriegová, E. (2020) · Biomedicines · doi:10.3390/biomedicines8060162 · Cited by 9
Musculoskeletal Health in Premature Ovarian Insufficiency. Part Two: Bone
Samad, N., Nguyen, H. H., Ebeling, P. R., & Milat, F. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1722849 · Cited by 7
Zhong, H.-Z., Li, M.-Y., Yin, X., Bin, C., Zhou, S.-Y., & Wei, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1043390 · Cited by 7
Diagnosis and Management of Neuroendocrine Disorders of Survivors of Brain Tumors
Erickson, D. Z., & Donegan, D. M. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_321059 · Cited by 6
Efthymiadis, A., Tsikopoulos, K., Mills, E. G., Milne, A., Dhillo, W. S., Abbara, A., & Comninos, A. N. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag005 · Cited by 5
Gut microbiota and aging: current understanding and future perspectives
Lan, M., Ding, H., Cao, Y., Liu, J., Tu, L., Fu, S., & Guo, W. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00499-0 · Cited by 6
Endocrine Disorders and Genital Infections Impair Gynecological Health in APECED (APS-1)
Saari, V., Laakso, S. M., Tiitinen, A. E., Mäkitie, O., & Holopainen, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.784195 · Cited by 7
Long-term health of women with genetic POI due to FSH-resistant ovaries
Luiro, K., Aittomäki, K., Jousilahti, P., & Tapanainen, J. S. (2019) · Endocrine Connections · doi:10.1530/ec-19-0244 · Cited by 4
Kim, C., Puterman, E. M., Hou, L., Slaughter, J. C., Terry, J. G., & Wellons, M. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.021 · Cited by 5
Evolution of Health Care in Turner Syndrome
Shankar, R. K., Gravholt, C. H., & Backeljauw, P. F. (2024) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.32124 · Cited by 4
Use of androgens at different stages of life: reproductive period
Nácul, A. P., Rezende, G. P., Yela, D. A., Maranhão, T. M. D. O., Costa, L. O. B. F., dos Reis, F. M., Maciel, G. A. R., Damásio, L. C. V. D. C., Silva, A. C. J. D. S. R. E., Lopes, V. M., et al. (2021) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1740610 · Cited by 4
Menopause Hormone Therapy in the Management of Postmenopausal Osteoporosis
Rozenberg, S., Vandromme, J., Revercez, P., Valcarenghi, M., & Joris, A. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000592 · Cited by 5
Geng, Y., Huang, Y., Liu, Z., Song, Y., Zhou, F., Zhang, Z., Li, F., Song, K., Dong, H., Hu, R., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157823 · Cited by 3
Zhu, X., Shi, X., Lu, J., Li, W., Liu, Y., Jiang, L., & Lv, Y. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-06067-z · Cited by 3
Lee, H. J., Park, M. J., Heo, J., Joo, B. S., & Joo, J. K. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2247094 · Cited by 3
Jiang, M. L., Gao, Y., Hou, H., Guo, J., Li, W., Qin, T., Shi, M., & Huang, L. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.02.013 · Cited by 5
Gemayel, J., Harb, F., Karam, F., Tahan, D., Younes, M., Saliba, Y., Chaker, D., Ibrahim, A., Azar, A., Chaaban, M., et al. (2025) · Contraception and Reproductive Medicine · doi:10.1186/s40834-025-00368-1 · Cited by 2
García-Sáenz, M. R., Ramírez-Renteria, C., Espinosa-Cárdenas, E., Sosa, E., Doval-Caballero, J. L. E., Palacios, P. C. G., Pérez, F. P., Ocampo-Torres, M. C., Catana-Hernández, R., Vázquez-Zaragoza, M. Á., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1775060 · Cited by 2
Tao, J., Wang, J., Jiang, W., Meng, Q., & Xu, M. (2021) · Journal of Nanomaterials · doi:10.1155/2021/9928051 · Cited by 2
Pituitary dysfunction after traumatic brain injury: A focus on screening, diagnosis, and treatment
Hacıoğlu, A., Karaca, Z., & Keleştimur, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00026-9 · Cited by 2
Engineering of ovarian tissue for ovarian dysfunctions: A review
Zhylkybekova, A., Koshmaganbetova, G. K., Rysmakhanov, M. S., Abenova, N. A., Mussin, N. M., Kaliyev, A. A., Mahdipour, M., & Tamadon, A. (2024) · Asian Pacific Journal of Reproduction · doi:10.4103/apjr.apjr_81_23 · Cited by 2
Possibilities of reproductive function realization in patients with premature ovarian insufficiency
Abdulaeva, A. S., Игоревна, К. П., & Bakhtiyarov, K. R. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-126 · Cited by 2
Yang, L., Zeng, L., Peng, Y., Liu, J., Li, X., & Yang, H. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116951 · Cited by 2
Transdermal versus oral hormone therapy in premature ovarian insufficiency
Beitl, K., Widmann, K., Marculescu, R., Krysiak, R. G., & Ott, J. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002588 · Cited by 2
Liu, Y., Ma, Y., Wang, L., Liu, C., Huang, X., & Zhang, J. (2025) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-025-00754-5 · Cited by 1
Saleha, S., Tahir, H., Zaffar, Z., Tariq, U. N., Jabeen, M., Khan, S. A., & Yasin, M. (2026) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/ceog47356 · Cited by 1
Yu, M., Ma, Y., Sun, X., Zhao, J., Sun, T., & Tang, L. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11097-6 · Cited by 1
Comprehensive Insights into Perrault Syndrome: Genetic Diversity and Clinical Implications
Tlili, A., & Khudeir, J. F. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02126-3 · Cited by 1
Metadata
- Authors
- Webber, L., Anderson, R. A., Davies, M., Janse, F., & Vermeulen, N.
- Affiliations
- University College Hospital (GB)
- MRC Centre for Reproductive Health (GB)
- University Medical Center Utrecht (NL)
- European Society of Human Reproduction and Embryology (BE)
- Corresponding author
- Webber, Lisa
- Venue
- Human Reproduction Open
- Publisher
- Oxford University Press (OUP)
- Published
- 2017
- Volume
- 2017
- Issue
- 2
- Pages
- hox007-hox007
- ISSN
- 2399-3529 (ISSN-L)
- PMC
- PMC6276684
- OpenAlex
- W2735417387
- Cited by
- 141
- References
- 138
- Citations by year
- 2026: 26 · 2025: 10 · 2024: 19 · 2023: 20 · 2022: 21 · 2021: 30 · 2020: 11 · 2019: 4
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Human Reproduction Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Funders
- European Society of Human Reproduction and Embryology
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- premature ovarian insufficiency, hormone replacement therapy, estrogen deficiency, vasomotor symptoms, genitourinary symptoms, bone protection, cardiovascular disease prevention, progestogens, androgens, transdermal estradiol, oral estrogen, ESHRE guidelines, life expectancy, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
